Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Amodio

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|November 5, 2011
Endocrine orchestration of cardiovascular, gastrointestinal and hypothalamic controlT Angelone, A M Quintieri, N Amodio, et al.
Cellular and Molecular Life Sciences : CMLS|September 8, 2012
Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injuryT Angelone, E Filice, T Pasqua, et al.
Current Cancer Drug Targets|June 8, 2012
Mouse models as a translational platform for the development of new therapeutic agents in multiple myelomaP Tassone, P Neri, R Burger, et al.
Current Cancer Drug Targets|June 8, 2012
Promises and challenges of MicroRNA-based treatment of multiple myelomaP Tagliaferri, M Rossi, M T Di Martino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 28, 2010
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heartT Angelone, E Filice, A M Quintieri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 26, 2010
Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonolsT Angelone, T Pasqua, D Di Majo, et al.
Cellular and Molecular Life Sciences : CMLS|October 2, 2017
Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotectionC Rocca, F Scavello, M C Granieri, et al.
ESMO Open|July 16, 2025
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patientsE A Martino, G Caridà, D Lofaro, et al.
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patientsN M Malara, F Givigliano, V Trunzo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|November 5, 2011
Endocrine orchestration of cardiovascular, gastrointestinal and hypothalamic controlT Angelone, A M Quintieri, N Amodio, et al.
Cellular and Molecular Life Sciences : CMLS|September 8, 2012
Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injuryT Angelone, E Filice, T Pasqua, et al.
Current Cancer Drug Targets|June 8, 2012
Mouse models as a translational platform for the development of new therapeutic agents in multiple myelomaP Tassone, P Neri, R Burger, et al.
Current Cancer Drug Targets|June 8, 2012
Promises and challenges of MicroRNA-based treatment of multiple myelomaP Tagliaferri, M Rossi, M T Di Martino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 28, 2010
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heartT Angelone, E Filice, A M Quintieri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 26, 2010
Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonolsT Angelone, T Pasqua, D Di Majo, et al.
Cellular and Molecular Life Sciences : CMLS|October 2, 2017
Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotectionC Rocca, F Scavello, M C Granieri, et al.
ESMO Open|July 16, 2025
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patientsE A Martino, G Caridà, D Lofaro, et al.
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patientsN M Malara, F Givigliano, V Trunzo, et al.
Pageof 2